These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 4607733)

  • 1. The control of deviant sexual behaviour by drugs. I. Behavioural changes following oestrogens and anti-androgens.
    Bancroft J; Tennent G; Loucas K; Cass J
    Br J Psychiatry; 1974 Sep; 125(0):310-5. PubMed ID: 4607733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endocrine changes in male sexual deviants after treatment with anti-androgens, oestrogens or tranquillizers.
    Murray MA; Bancroft JH; Anderson DC; Tennent TG; Carr PJ
    J Endocrinol; 1975 Nov; 67(2):179-88. PubMed ID: 1107462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A double-blind placebo controlled trial of medroxyprogesterone acetate and cyproterone acetate with seven pedophiles.
    Cooper AJ; Sandhu S; Losztyn S; Cernovsky Z
    Can J Psychiatry; 1992 Dec; 37(10):687-93. PubMed ID: 1473073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progestogens in the treatment of male sex offenders: a review.
    Cooper AJ
    Can J Psychiatry; 1986 Feb; 31(1):73-9. PubMed ID: 2936441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Inhibition of ovulation with 35 micrograms of ethinyl estradiol and 2 mg of cyproterone acetate (Diane 35)].
    Spona J; Huber J; Schmidt JB
    Geburtshilfe Frauenheilkd; 1986 Jul; 46(7):435-8. PubMed ID: 3093307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-estrogens and plasma proteins. II. Contraceptive drugs and gestagens.
    Barbosa J; Seal US; Doe RP
    J Clin Endocrinol Metab; 1973 Apr; 36(4):706-14. PubMed ID: 4119677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical evaluation of the therapeutic effectiveness of ethinyl oestradiol and oestrone sulphate on prolonged bleeding in women using depot medroxyprogesterone acetate for contraception. World Health Organization, Special Programme of Research, Development and Research Training in Human Reproduction, Task Force on Long-acting Systemic Agents for Fertility Regulation.
    Said S; Sadek W; Rocca M; Koetsawang S; Kirwat O; Piya-Anant M; Dusitsin N; Sethavanich S; Affandi B; Hadisaputra W; Kazi A; Ramos RM; d'Arcangues C; Belsey EM; Noonan E; Olayinka I; Pinol A
    Hum Reprod; 1996 Oct; 11 Suppl 2():1-13. PubMed ID: 8982739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Male contraception and vasectomy.
    Emperaire JC; Audebert A; Mattei A
    Contracept Fertil Sex (Paris); 1977; 5(4):335-42. PubMed ID: 12260083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new association of ethinylestradiol (0.035 mg) cyproterone acetate (2 mg) in the therapy of polycystic ovary syndrome.
    Falsetti L; Dordoni D; Gastaldi C; Gastaldi A
    Acta Eur Fertil; 1986; 17(1):19-25. PubMed ID: 2941960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hirsutism treated with cyproterone acetate and ethinyl estradiol. Influence on androgens in the serum and urine and on urinary cortisol].
    Nielsen DR; Larsen J; Pedersen IM; Starup J
    Ugeskr Laeger; 1985 Aug; 147(33):2589-93. PubMed ID: 2933857
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of ethinyl estradiol combined with desogestrel and cyproterone acetate on glucose tolerance and insulin response to an oral glucose load: a one-year randomized, prospective, comparative trial.
    Jandrain BJ; Humblet DM; Jaminet CB; Scheen AJ; Gaspard UJ; Lefebvre PJ
    Am J Obstet Gynecol; 1990 Jul; 163(1 Pt 2):378-81. PubMed ID: 2142578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical use of ethinyl estradiol in combination with cyproterone acetate. Study based on 50 cases (author's transl)].
    Henrion R; Laveissiere MN
    Contracept Fertil Sex (Paris); 1982 Oct; 10(10):653-7. PubMed ID: 12338447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sadistic homosexual pedophilia: treatment with cyproterone acetate: a single case study.
    Bradford JM; Pawlak A
    Can J Psychiatry; 1987 Feb; 32(1):22-30. PubMed ID: 2949821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyproterone acetate for male hypersexuality.
    Davies TS
    J Int Med Res; 1974; 2(2):159-63. PubMed ID: 4468912
    [No Abstract]   [Full Text] [Related]  

  • 15. [Hirsutism treated with cyproterone acetate and ethinyl estradiol. Evaluation of the clinical effect].
    Pedersen IM; Nielsen DR; Larsen J; Starup J
    Ugeskr Laeger; 1985 Aug; 147(33):2594-6. PubMed ID: 2933858
    [No Abstract]   [Full Text] [Related]  

  • 16. Control of fertility with oral medication.
    Diddle AW; Watts GF; Gardner WH; Williamson PJ
    West J Surg Obstet Gynecol; 1964; 72():222-9. PubMed ID: 12305556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A placebo-controlled trial of the antiandrogen cyproterone acetate in deviant hypersexuality.
    Cooper AJ
    Compr Psychiatry; 1981; 22(5):458-65. PubMed ID: 6230209
    [No Abstract]   [Full Text] [Related]  

  • 18. The cyproteronacetat treatment of sexual offenders.
    Berner W; Brownstone G; Sluga W
    Neurosci Biobehav Rev; 1983; 7(3):441-3. PubMed ID: 6230546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyproterone acetate.
    Mothes C
    Lancet; 1976 Nov; 2(7993):1020. PubMed ID: 62231
    [No Abstract]   [Full Text] [Related]  

  • 20. [A new ovulation inhibitor antiandrogen].
    Millet-part A; Blanes-espi A; Ferrer-barriendos J; Siqueira L; Acosta E
    J Bras Ginecol; 1984 Mar; 94(3):91-7. PubMed ID: 12266391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.